Belocura, Pedro, JR.. T.

HRN: 22-07-74  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2022
CEFTRIAXONE 1G (VIAL)
10/21/2022
10/27/2022
IVTT
2g LD; 1g OD
Q24
Cholangitis
Waiting Final Action 
10/21/2022
METRONIDAZOLE 500MG (TAB)
10/21/2022
10/28/2022
PER OREM
500mg
TID
Cholangitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: